Case Report: A rare case of esophageal squamous cell carcinoma with metastases to the pancreas and stomach - Report - MDSpire

Case Report: A rare case of esophageal squamous cell carcinoma with metastases to the pancreas and stomach

  • By

  • Yuhang Lv

  • Yanting Jiang

  • Kaiyuan Hui

  • Xiaodong Jiang

  • June 11, 2026

  • 0 min

Share

Clinical Report: Uncommon Case of Esophageal Squamous Cell Carcinoma Metastasizing to the Pancreas and Stomach

Overview

This report details a rare case of esophageal squamous cell carcinoma (ESCC) metastasizing to the pancreas and stomach 37 months post-radiotherapy. The patient underwent radical surgical resection followed by immunochemotherapy, highlighting the need for awareness of atypical metastatic presentations in ESCC.

Background

Esophageal cancer, particularly ESCC, is known for its aggressive nature and poor prognosis. While distant metastases are common, pancreatic and gastric metastases from ESCC are exceptionally rare, making this case significant. Understanding such rare occurrences is crucial for accurate diagnosis and effective treatment planning.

Data Highlights

No numerical data available in the article.

Key Findings

['ESCC can metastasize to the pancreas and stomach, which is extremely rare.', 'The patient had a prolonged disease-free interval of 37 months after radiotherapy before the discovery of metastases.', 'Radical surgical resection was performed, confirming the presence of metastases through histopathological analysis.', 'The patient received a systemic regimen of immune checkpoint inhibitors combined with platinum-based chemotherapy postoperatively.', 'This case emphasizes the importance of considering rare metastases in patients with a history of ESCC.']

Clinical Implications

Clinicians should maintain a high index of suspicion for rare metastatic sites in patients with a history of ESCC, even after extended disease-free intervals. Multidisciplinary approaches, including surgical resection and immunochemotherapy, may improve outcomes in such atypical cases.

Conclusion

This case underscores the rarity of pancreatic and gastric metastases from ESCC and the importance of a comprehensive treatment strategy. Awareness and timely intervention can significantly impact patient management and outcomes.

Related Resources & Content

  1. Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline Update | Journal of Clinical Oncology, 2026 -- Guideline-based management for unresectable or metastatic ESCC
  2. Pancreatic Metastases of Esophageal Squamous Cell Carcinoma: A Case Report and Review of the Literature | MDPI, 2023 -- Review of rare ESCC metastases
  3. Journal of Gastrointestinal Surgery — Sarcomatoid Malignant Mesothelioma: A Rare Case in the Pancreas
  4. Frontiers in Surgery — When Pancreatic Cancer Is Not Cancer: A Rare Case of Pancreatic Head Paraganglioma with Life-Threatening Delayed Pseudoaneurysm Bleeding
  5. Favorable long-term outcomes following concurrent resection of the esophagus, stomach, and pancreas
  6. Journal of Gastrointestinal Surgery — Case Study and Literature Review on Pancreatic Serous Cystadenocarcinoma
  7. Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline Update | Journal of Clinical Oncology
  8. Pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer: 5-year extended follow-up for the randomized phase III KEYNOTE-590 study - PMC
  9. Pancreatic Metastases of Esophageal Squamous Cell Carcinoma: A Case Report and Review of the Literature | MDPI

Original Source(s)

Related Content